Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Standard Precaution

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...

Methods for Controlling Microbial Growth

Methods for Controlling Microbial Growth

Microbial growth control refers to various methods employed to inhibit, reduce, or eliminate microorganisms to ensure safety and hygiene across different settings. These methods are categorized based on the target environment and the level of microbial control required.Biocides are versatile agents designed to control microorganisms by either inhibiting their growth or outright killing them. These agents work through various physical, chemical, mechanical, or biological mechanisms. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).

The Journal of hospital infection·2022

Same author

Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile.

Journal of clinical microbiology·2021

Same author

Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2.

Infection prevention in practice·2021

Same author

The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model.

The Journal of hospital infection·2021

Same author

Protecting the Microbiota.

The Journal of infectious diseases·2021

Same author

Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.

The Journal of antimicrobial chemotherapy·2020

Search research articles

Related Experiment Video

Updated: May 26, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

MRSA prevention strategies and current guidelines.

F M Byrne¹, M H Wilcox

¹Department of Medical Microbiology, Leeds Teaching Hospitals & University of Leeds, UK.

|December 27, 2011

Summary

Preventing MRSA infections involves enhanced screening, decolonisation, and judicious antibiotic use. Future Staphylococcus aureus vaccines may offer cost-effective control of these devastating bone and soft tissue infections.

Area of Science:

Infectious Diseases
Public Health Policy
Antimicrobial Stewardship

Background:

Methicillin-resistant Staphylococcus aureus (MRSA) soft tissue and bone infections pose significant patient and healthcare burdens.
Mandatory MRSA screening for emergency admissions in England (from 2011) is being implemented alongside existing elective screening.
Current rapid screening technologies lack proven cost-effectiveness, necessitating continued reliance on standard infection control measures.

Purpose of the Study:

To review current and future strategies for preventing MRSA soft tissue and bone infections.
To highlight the importance of infection control policies, decolonisation, and antimicrobial stewardship in MRSA prevention.
To discuss the role of operating theatre protocols and potential impact of a Staphylococcus aureus vaccine.

More Related Videos

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

Related Experiment Videos

Last Updated: May 26, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)

Published on: February 9, 2011

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP

Published on: April 9, 2013

Main Methods:

Review of existing literature and policy documents on MRSA prevention strategies.
Analysis of infection control measures, including screening, isolation, and decolonisation.
Evaluation of antimicrobial prescribing guidelines and their impact on MRSA carriage.
Consideration of surgical site infection prevention protocols and future vaccine development.

Main Results:

Standard infection control policies, including isolation and decolonisation, remain crucial due to screening limitations.
Antimicrobial stewardship, particularly reducing fluoroquinolone and third-generation cephalosporin use, can help control MRSA.
Optimized operating theatre protocols and adjusted antibiotic prophylaxis are key for preventing orthopaedic MRSA infections.
A modelled cost-effective Staphylococcus aureus vaccine represents a potential future prevention strategy.

Conclusions:

A multi-faceted approach combining enhanced screening, rigorous infection control, and strategic antimicrobial use is essential for MRSA prevention.
Adapting antibiotic prophylaxis and surgical protocols based on local MRSA prevalence is recommended.
Future developments, such as a Staphylococcus aureus vaccine, hold promise for more effective and cost-effective MRSA control.